56 related articles for article (PubMed ID: 7572417)
1. Genetic engineering of the donor species to control hyperacute xenograft rejection.
White DJ; Cozzi E; Langford G; Oglesby T; Wang MW; Wright L; Wallwork J
Adv Nephrol Necker Hosp; 1995; 24():331-40. PubMed ID: 7572417
[No Abstract] [Full Text] [Related]
2. Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection.
Cary N; Moody J; Yannoutsos N; Wallwork J; White D
Transplant Proc; 1993 Feb; 25(1 Pt 1):400-1. PubMed ID: 7679815
[No Abstract] [Full Text] [Related]
3. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.
Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF
Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279
[TBL] [Abstract][Full Text] [Related]
4. Possibility of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation.
Miyagawa S; Shirakura R; Matsumiya G; Nakata S; Matsuda H; Hatanaka M; Matsumoto M; Seya T
Transplant Proc; 1994 Jun; 26(3):1235-8. PubMed ID: 7518114
[No Abstract] [Full Text] [Related]
5. The control of hyperacute rejection by genetic engineering of the donor species.
White DJ; Cozzi E; Langford G; Oglesby T; Wang MW; Wright L; Wallwork J
Eye (Lond); 1995; 9 ( Pt 2)():185-9. PubMed ID: 7556715
[TBL] [Abstract][Full Text] [Related]
6. Studies on transfer of primate membrane-associated complement inhibitors from recipient blood to porcine donor organs.
Kroshus TJ; Bolman RM; Dalmasso AP
Transplant Proc; 1996 Apr; 28(2):601-2. PubMed ID: 8623295
[No Abstract] [Full Text] [Related]
7. Complement regulatory molecules: application to therapy and transplantation.
Morgan BP
Immunol Today; 1995 Jun; 16(6):257-9. PubMed ID: 7544975
[No Abstract] [Full Text] [Related]
8. Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase).
Ramírez P; Montoya MJ; Ríos A; García Palenciano C; Majado M; Chávez R; Muñoz A; Fernández OM; Sánchez A; Segura B; Sansano T; Acosta F; Robles R; Sánchez F; Fuente T; Cascales P; González F; Ruiz D; Martínez L; Pons JA; Rodríguez JI; Yélamos J; Cowan P; d'Apice A; Parrilla P
Transplant Proc; 2005 Nov; 37(9):4103-6. PubMed ID: 16386637
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells.
Nagahama M; Shiraishi M; Oshiro T; Taira K; Sugawa H; Nozato E; Nomura H; Nagamine M; Muto Y
Transpl Int; 2002 May; 15(5):205-11. PubMed ID: 12012040
[TBL] [Abstract][Full Text] [Related]
10. Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF.
Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Marinucci G; Melli CM; Bruzzone P; Alfani D; Cortesini R; Rossini M
Transplant Proc; 1996 Feb; 28(1):127-9. PubMed ID: 8644143
[No Abstract] [Full Text] [Related]
11. In vitro and in vivo studies to prevent hyperacute rejection.
Miyagawa S; Mikata M; Matsuda H; Ikawa M; Okabe M; Nagasawa S; Matsumoto M; Seya T; Shirakura R
Transplant Proc; 1996 Apr; 28(2):1031-3. PubMed ID: 8623217
[No Abstract] [Full Text] [Related]
12. Development and analysis of transgenic pigs expressing the human complement regulatory protein CD59 and DAF.
Byrne G; McCurry K; Martin M; Platt J; Logan J
Transplant Proc; 1996 Apr; 28(2):759. PubMed ID: 8623385
[No Abstract] [Full Text] [Related]
13. CD46 (MCP) confers protection from lysis by xenogeneic antibodies.
Loveland BE; Johnstone RW; Russell SM; Thorley BR; McKenzie IF
Transplant Proc; 1993 Feb; 25(1 Pt 1):396-7. PubMed ID: 8438351
[No Abstract] [Full Text] [Related]
14. The molecular basis of CD46 polymorphic expression and demonstration of a protective role against lysis by xenosera.
Loveland B; Russell S; Purcell D; Johnstone R; Thorley B; Sparrow R; McKenzie I
Transplant Proc; 1992 Apr; 24(2):685-6. PubMed ID: 1632880
[No Abstract] [Full Text] [Related]
15. Functional feature of C5b-8-step lysis of swine endothelial cell- transfected CD59.
Miyagawa S; Shirakura R; Mikata S; Tanemura M; Fukushima N; Matsuda H; Terado A; Hatanaka M; Matsumoto M; Seya T
Transplant Proc; 1996 Apr; 28(2):597-8. PubMed ID: 8623293
[No Abstract] [Full Text] [Related]
16. Effective antiplatelet therapy does not prolong transgenic pig to baboon cardiac xenograft survival.
Schirmer JM; Fass DN; Byrne GW; Tazelaar HD; Logan JS; McGregor CG
Xenotransplantation; 2004 Sep; 11(5):436-43. PubMed ID: 15303980
[TBL] [Abstract][Full Text] [Related]
17. Functional expression of human CD59 in transgenic mice.
Somerville CA; Kyriazis AG; McKenzie A; Allison J; Pearse MJ; D'Apice AJ
Transplantation; 1994 Dec; 58(12):1430-5. PubMed ID: 7528953
[No Abstract] [Full Text] [Related]
18. The regulation of membrane cofactor protein (CD46) expression by the 3' untranslated region in transgenic mice.
Miyagawa S; Mikata S; Tanaka H; Ikawa M; Kominami K; Seya T; Nishimune Y; Shirakura R; Okabe M
Biochem Biophys Res Commun; 1997 Apr; 233(3):829-33. PubMed ID: 9168942
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part II: xenogeneic perfusion of the porcine liver in vivo.
Shiraishi M; Oshiro T; Nozato E; Nagahama M; Taira K; Nomura H; Sugawa H; Muto Y
Transpl Int; 2002 May; 15(5):212-9. PubMed ID: 12012041
[TBL] [Abstract][Full Text] [Related]
20. The study of mitoxantrone as a potential immunosuppressor in transgenic pig renal xenotransplantation in baboons: comparison with cyclophosphamide.
Ashton-Chess J; Meurette G; Karam G; Petzold T; Minault D; Naulet J; Tesson L; Plat M; Anegon I; Soulillou JP; Blancho G
Xenotransplantation; 2004 Mar; 11(2):112-22. PubMed ID: 14962273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]